Viewing Study NCT06543069


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-01-11 @ 10:29 AM
Study NCT ID: NCT06543069
Status: RECRUITING
Last Update Posted: 2024-08-07
First Post: 2024-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module